Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999328 | Urologic Oncology: Seminars and Original Investigations | 2016 | 9 Pages |
Abstract
With the exception of men who present with all 3 intermediate-risk factors, a significant association with decreased all-cause mortality risk and ADT was not observed for patients with intermediate-risk prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Arya M.D., Chad G. M.D., Bernard L. Ph.D., Hirotatsu Ph.D., David M.D., Brian D. M.D., M.P.H.,